C9orf72 and amyotrophic lateral sclerosis: A recent study, targeting imaging-based strategies to detect and evaluate an ESCRT-III-based pathway and therapy in >40 different sporadic and C9orf72 ALS and control iPS cell lines, approached the size of a small clinical trial25.